[Federal Register Volume 68, Number 244 (Friday, December 19, 2003)]
[Notices]
[Page 70816]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-31386]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee on Special Studies Relating to the Possible 
Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch 
Hand Advisory Committee); Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Advisory Committee on Special Studies Relating 
to the Possible Long-Term Health Effects of Phenoxy Herbicides and 
Contaminants (Ranch Hand Advisory Committee).
    General Function of the Committee: To advise the Secretary and the 
Assistant Secretary for Health concerning its oversight of the conduct 
of the Ranch Hand Study by the U.S. Air Force and provide scientific 
oversight of the Department of Veterans Affairs Army Chemical Corps 
Vietnam Veterans Health Study, and other studies in which the Secretary 
or the Assistant Secretary for Health believes involvement by the 
committee is desirable.
    Date and Time: The meeting will be held on January 21, 2004, 8 a.m. 
to 3:30 p.m.
    Location: Food and Drug Administration, 5630 Fishers Lane, rm. 
1066, Rockville, MD 20857.
    Contact Person: Leonard Schechtman, National Center for 
Toxicological Research (HFT-10), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-6696, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 3014512560. Please call the Information Line 
for up-to-date information on this meeting.
    Agenda: The U.S. Air Force will provide a program management update 
and present information on the following topics: Syndrome X; cancer and 
hepatitis in the comparison group vs. years in Southeast Asia; prostate 
cancer; adipose tissue study results; and memory loss and end of study 
transition.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by January 9, 
2004. Oral presentations from the public will be scheduled between 
approximately 1:30 p.m. to 2:30 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before January 6, 2004, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Leonard Schechtman 
at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: December 15, 2003.
William K. Hubbard,
Associate Commissioner for Policy and Planning.
[FR Doc. 03-31386 Filed 12-18-03; 8:45 am]
BILLING CODE 4160-01-S